D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Liberty Media Series C
FWONK
|
+$430M |
| 2 |
Alibaba
BABA
|
+$364M |
| 3 |
HP
HPQ
|
+$298M |
| 4 |
Pfizer
PFE
|
+$258M |
| 5 |
Booking.com
BKNG
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$602M |
| 2 |
Liberty Media Series A
FWONA
|
+$321M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
GE Aerospace
GE
|
+$233M |
| 5 |
SNDK
SANDISK CORP
SNDK
|
+$183M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.89% |
| 2 | Consumer Discretionary | 8.28% |
| 3 | Energy | 7.75% |
| 4 | Healthcare | 6.77% |
| 5 | Communication Services | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
Hasbro
HAS
$13.5B
| $3.38M | ﹤0.01% |
61,500
| – | – |
|
|
SNCR
1802
DELISTED
Synchronoss Technologies
SNCR
| $3.37M | ﹤0.01% |
8,182
+6,354
| +348% | +$2.29M |
|
|
MHR
1803
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
| $3.37M | ﹤0.01% |
604,975
-497,235
| -45% | -$3.29M |
|
1804
Acadia Pharmaceuticals
ACAD
$4.51B
| $3.36M | ﹤0.01% |
135,639
+8,424
| +7% | +$197K |
|
|
CBK
1805
DELISTED
Christopher & Banks Corporation
CBK
| $3.35M | ﹤0.01% |
339,072
-170,499
| -33% | -$1.63M |
|
1806
PUT
Equinix
EQIX
$99.4B
| $3.35M | ﹤0.01% |
15,759
+4,959
| +46% | +$1.06M |
|
|
SLXP
1807
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $3.34M | ﹤0.01% |
+21,384
| New | +$3.1M |
|
|
WBMD
1808
CALL
DELISTED
WebMD Health Corp.
WBMD
| $3.34M | ﹤0.01% |
79,800
+20,000
| +33% | +$965K |
|
|
AGN
1809
CALL
DELISTED
Allergan Inc
AGN
| $3.33M | ﹤0.01% |
18,700
| – | – |
|
|
ARI
1810
Apollo Commercial Real Estate
ARI
$864M
| $3.33M | ﹤0.01% |
211,933
+171,674
| +426% | +$2.84M |
|
1811
Angi Inc
ANGI
$247M
| $3.33M | ﹤0.01% |
52,218
-16,049
| -24% | -$1.36M |
|
|
1812
PUT
Acadia Pharmaceuticals
ACAD
$4.51B
| $3.32M | ﹤0.01% |
134,100
| – | – |
|
|
XOXO
1813
DELISTED
Xo Group Inc
XOXO
| $3.32M | ﹤0.01% |
296,060
-680
| -0.2% | -$8.02K |
|
|
COWN
1814
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $3.32M | ﹤0.01% |
221,228
-83,308
| -27% | -$1.36M |
|
1815
Cytokinetics
CYTK
$10.6B
| $3.31M | ﹤0.01% |
941,711
+104,362
| +12% | +$438K |
|
|
SIR
1816
DELISTED
SELECT INCOME REIT
SIR
| $3.31M | ﹤0.01% |
313,058
-106,300
| -25% | -$1.28M |
|
|
WW
1817
PUT
DELISTED
WW International
WW
| $3.31M | ﹤0.01% |
120,500
-24,500
| -17% | -$559K |
|
|
GGP
1818
DELISTED
GGP Inc.
GGP
| $3.31M | ﹤0.01% |
140,402
-425,282
| -75% | -$10.2M |
|
1819
PUT
U-Haul Holding Co
UHAL
$14B
| $3.3M | ﹤0.01% |
126,000
-176,000
| -58% | -$4.87M |
|
|
MNDT
1820
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $3.29M | ﹤0.01% |
+107,741
| New | +$3.57M |
|
1821
PUT
Simon Property Group
SPG
$76.4B
| $3.29M | ﹤0.01% |
+20,000
| New | +$3.37M |
|
|
COV
1822
PUT
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| $3.29M | ﹤0.01% |
38,000
| – | – |
|
1823
PUT
Allegion
ALLE
$13.5B
| $3.28M | ﹤0.01% |
+68,904
| New | +$3.61M |
|
1824
Silicon Laboratories
SLAB
$7.14B
| $3.28M | ﹤0.01% |
80,738
-143,644
| -64% | -$6.32M |
|
1825
PUT
Liberty Global Class C
LBTYK
$3.5B
| $3.28M | ﹤0.01% |
+98,764
| New | +$3.33M |
|
Similar funds
D.E. Shaw & Co's Q3 2014 Portfolio in Review
As of Q3 2014, D.E. Shaw & Co held 4,729 positions worth $77.2B, up 5.1% from $73.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co deployed $3.39B of net new capital in Q3 2014, opening 599 new positions and adding to 1,385 existing holdings. Its largest new stake was Liberty Media Series C: 16,804,239 shares worth $422M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Liberty Media Series A, an estimated $321M trimmed.
- D.E. Shaw & Co's largest Q3 2014 buy was Liberty Media Series C: 16,804,239 shares worth $422M.
- D.E. Shaw & Co added most to HP in Q3 2014, an estimated $298M increase.
- D.E. Shaw & Co's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $321M.
- D.E. Shaw & Co fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $602M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $77.2B portfolio in Q3 2014.
- D.E. Shaw & Co opened 599 new positions and closed 674 in Q3 2014.
- D.E. Shaw & Co's portfolio value rose 5.1% quarter-over-quarter to $77.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.